Stock SCP SCOPE FLUIDICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Company Scope Fluidics S.A.

Equities

SCP

PLSCPFL00018

Biotechnology & Medical Research

Market Closed - Warsaw S.E.
Other stock markets
 11:58:25 2024-04-19 am EDT 		5-day change 1st Jan Change
178.4 PLN -3.98% Intraday chart for Scope Fluidics S.A. -5.21% -8.98%
2023 Scope Fluidics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Scope Fluidics S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI

Business Summary

Scope Fluidics SA is a Poland-based company engaged in the biotechnology. The Company focuses on diagnostic and med-tech solutions. It develops disposable microfluidic systems for the collection of micro-samples of blood, as well as storage of reagents for diagnostic markers. Its projects include PCR ONE system that delivers the bacterial and viral pathogen detection, and BacterOMIC system that delivers information on bacterial susceptibility to antibiotics and on the resistance mechanisms. The Company provides access to laboratories and workshops for developed projects, as well as administrative facilities and services, including financing. In addition, it cooperates with doctors, medical personnel, project managers, engineers and academics.

Number of employees: 30

Sales per Business

PLN in Million2022Weight2023Weight Delta
Innovation in the Field of Diagnosis and Health Care
100.0 %
0 100.0 % 1 100.0 % +27.72%

Sales per region

PLN in Million2022Weight2023Weight Delta
Poland
100.0 %
0 100.0 % 1 100.0 % +27.72%

Managers

Managers TitleAgeSince
Piotr Garstecki CEO
 Chief Executive Officer 48 09-12-31
Marcin Izydorzak FOU
 Founder 50 09-12-31
Szymon Ruta DFI
 Director of Finance/CFO 48 16-10-31
Anna Siemianowska ADM
 Chief Administrative Officer - 10-12-31
Maja Czerwinska IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Robert Boguslaw Przytula CHM
 Chairman 49 17-03-06
Andrzej Chadzynski BRD
 Director/Board Member 48 17-03-06
Robert Piotr Holyst FOU
 Founder 61 09-12-31
Patryk Mikucki BRD
 Director/Board Member 49 18-06-28
Karolina Radziszewska BRD
 Director/Board Member - -
Joanna Rzempala BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,725,930 2,001,901 ( 73.44 %) 0 73.44 %

Shareholders

NameEquities%Valuation
IPOPEMA TFI SA
17.70 %
482,455 17.70 % 24 M zł
Piotr Garstecki
13.75 %
374,924 13.75 % 19 M zł
Marcin Izydorzak
13.44 %
366,355 13.44 % 19 M zł
ESALIENS TFI SA
5.509 %
150,176 5.509 % 8 M zł
TFI PZU SA
1.119 %
30,500 1.119 % 2 M zł
MetLife TFI SA
0.0869 %
2,368 0.0869 % 119 951 zł
Rockbridge TFI
0.0676 %
1,843 0.0676 % 93 357 zł

Company contact information

Scope Fluidics SA

Ogrodowa 58 Street 9th Floor

00-876, Warsaw

+48 22 376 2114

http://www.scopefluidics.com
address Scope Fluidics S.A.(SCP)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Diagnostics & Testing

Sector Bio Diagnostics & Testing

1st Jan change Capi.
SCOPE FLUIDICS S.A. Stock Scope Fluidics S.A.
-8.98% 120M
IOVANCE BIOTHERAPEUTICS, INC. Stock Iovance Biotherapeutics, Inc.
+39.11% 3.16B
BGI GENOMICS CO., LTD. Stock BGI Genomics Co., Ltd.
-20.67% 2B
GUARDANT HEALTH, INC. Stock Guardant Health, Inc.
-40.59% 1.96B
VERACYTE, INC. Stock Veracyte, Inc.
-29.30% 1.46B
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock Maravai LifeSciences Holdings, Inc.
+11.45% 966M
SEEGENE, INC. Stock Seegene, Inc.
-6.33% 718M
CAREDX, INC Stock CareDx, Inc
-30.75% 430M
ADAPTIVE BIOTECHNOLOGIES CORPORATION Stock Adaptive Biotechnologies Corporation
-51.02% 348M
CURIOX BIOSYSTEMS CO., LTD Stock Curiox Biosystems Co., Ltd
-2.58% 286M
Bio Diagnostics & Testing
  1. Stock Market
  2. Equities
  3. SCP Stock
  4. Company Scope Fluidics S.A.